Annual Current Liabilities
$30.99 M
-$3.89 M-11.16%
December 31, 2022
Summary
- As of February 10, 2025, SGTX annual total current liabilities is $30.99 million, with the most recent change of -$3.89 million (-11.16%) on December 31, 2022.
- During the last 3 years, SGTX annual current liabilities has fallen by -$9.38 million (-23.23%).
Performance
SGTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$25.25 M
-$3.74 M-12.91%
June 30, 2023
Summary
- As of February 10, 2025, SGTX quarterly total current liabilities is $25.25 million, with the most recent change of -$3.74 million (-12.91%) on June 30, 2023.
- Over the past year, SGTX quarterly current liabilities has dropped by -$8.07 million (-24.23%).
Performance
SGTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SGTX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.2% | -24.2% |
| 3 y3 years | -23.2% | - |
| 5 y5 years | +6.1% | -37.5% |
SGTX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.2% | at low | -31.8% | at low |
| 5 y | 5-year | -34.1% | at low | -46.3% | at low |
| alltime | all time | -34.1% | -5.8% | -46.3% | at low |
Sigilon Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $25.25 M(-12.9%) |
| Mar 2023 | - | $28.99 M(-6.5%) |
| Dec 2022 | $30.99 M(-11.2%) | $30.99 M(+1.4%) |
| Sep 2022 | - | $30.55 M(-8.3%) |
| Jun 2022 | - | $33.32 M(-10.1%) |
| Mar 2022 | - | $37.05 M(+6.2%) |
| Dec 2021 | $34.89 M | $34.89 M(-14.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $40.87 M(-7.9%) |
| Jun 2021 | - | $44.39 M(+28.7%) |
| Mar 2021 | - | $34.48 M(-26.7%) |
| Dec 2020 | $47.02 M(+16.5%) | $47.02 M(+3.7%) |
| Sep 2020 | - | $45.33 M(+12.3%) |
| Dec 2019 | $40.38 M(+38.3%) | $40.38 M |
| Dec 2018 | $29.20 M | - |
FAQ
- What is Sigilon Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Sigilon Therapeutics?
- What is Sigilon Therapeutics annual current liabilities year-on-year change?
- What is Sigilon Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sigilon Therapeutics?
- What is Sigilon Therapeutics quarterly current liabilities year-on-year change?
What is Sigilon Therapeutics annual total current liabilities?
The current annual current liabilities of SGTX is $30.99 M
What is the all time high annual current liabilities for Sigilon Therapeutics?
Sigilon Therapeutics all-time high annual total current liabilities is $47.02 M
What is Sigilon Therapeutics annual current liabilities year-on-year change?
Over the past year, SGTX annual total current liabilities has changed by -$3.89 M (-11.16%)
What is Sigilon Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of SGTX is $25.25 M
What is the all time high quarterly current liabilities for Sigilon Therapeutics?
Sigilon Therapeutics all-time high quarterly total current liabilities is $47.02 M
What is Sigilon Therapeutics quarterly current liabilities year-on-year change?
Over the past year, SGTX quarterly total current liabilities has changed by -$8.07 M (-24.23%)